The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Performance of a prognostic genomic signature for early-stage NSCLC in matched fresh frozen and RNA-stabilized tissue.
Shuguang Huang
Employment or Leadership Position - Precision Therapeutics
Stock Ownership - Precision Therapeutics
Amy L Ewing
Employment or Leadership Position - Precision Therapeutics
Stock Ownership - Precision Therapeutics
Nicholas J Reitze
Employment or Leadership Position - Precision Therapeutics
Stock Ownership - Precision Therapeutics
Arlette H Uihlein
Employment or Leadership Position - Precision Therapeutics
Stock Ownership - Precision Therapeutics
Dakun Wang
Employment or Leadership Position - Precision Therapeutics
Stock Ownership - Precision Therapeutics
Michael J Gabrin
Employment or Leadership Position - Precision Therapeutics
Stock Ownership - Precision Therapeutics
Katherine E. Keating
No relevant relationships to disclose
Jude Mulligan
No relevant relationships to disclose
Claire Wilson
No relevant relationships to disclose
Timothy Davison
No relevant relationships to disclose
Stuart McKenzie
No relevant relationships to disclose
Ming-Sound Tsao
Consultant or Advisory Role - Precision Therapeutics (U)
Honoraria - Precision Therapeutics
Research Funding - Med BioGene
Frances A. Shepherd
No relevant relationships to disclose
Stacey L Brower
Employment or Leadership Position - Precision Therapeutics
Stock Ownership - Precision Therapeutics